FundingMachineFunding Atlas programme
Reconstructive Transplant Research Program
CDMRP
JurisdictionUnited StatesFunding typeGrant
Documented facts
Key facts
- Funder
- CDMRP
- Jurisdiction
- United States
- Record type
- Opportunity
- Funding type
- Grant
- Amount
- Not published by the funder
- Last deadline
- Closed 21 October 2026
Published rule provenance
Eligibility information
- Country / jurisdiction
Rule not encoded
- Organisation type
Rule not encoded
- Company size
Rule not encoded
- Stage
Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
Clinical trials are not allowed.
Quoted sourceEligibility rule, quoted from the funder
Clinical trials are not allowed.
Quoted source- Therapeutic area
Rule not encoded
- Amount sought
Rule not encoded
Further quoted conditions
Eligibility rule, quoted from the funder: amount_requested
The maximum allowable funding for the entire period of performance is $200,000 for total costs.Quoted source
Eligibility rule, quoted from the funder: amount_requested
The maximum allowable funding for the entire period of performance is $1 million for total costs.Quoted source
Site note: This record is not advice or a funder decision.